BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 17348440)

  • 21. Differentiation pathways in primary invasive breast carcinoma as suggested by intermediate filament and biopathological marker expression.
    Santini D; Ceccarelli C; Taffurelli M; Pileri S; Marrano D
    J Pathol; 1996 Aug; 179(4):386-91. PubMed ID: 8869285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triple negative breast cancer: a study from the point of view of basal CK5/6 and HER-1.
    Pintens S; Neven P; Drijkoningen M; Van Belle V; Moerman P; Christiaens MR; Smeets A; Wildiers H; Vanden Bempt I
    J Clin Pathol; 2009 Jul; 62(7):624-8. PubMed ID: 19561231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome of invasive ductal breast carcinoma.
    van der Vegt B; de Roos MA; Peterse JL; Patriarca C; Hilkens J; de Bock GH; Wesseling J
    Histopathology; 2007 Sep; 51(3):322-35. PubMed ID: 17645748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Triple-negative breast carcinoma in women from Vietnam and the United States: characterization of differential marker expression by tissue microarray.
    Williams DJ; Cohen C; To TV; Page AJ; Lawson D; Sussman ZM; Nassar A
    Hum Pathol; 2009 Aug; 40(8):1176-81. PubMed ID: 19368951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inference of the Basal epithelial phenotype in breast carcinoma from differential marker expression, using tissue microarrays in triple negative breast cancer and women younger than 35.
    Nassar A; Sussman ZM; Lawson D; Cohen C
    Breast J; 2012 Sep; 18(5):399-405. PubMed ID: 22882580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RET finger protein expression in invasive breast carcinoma: relationship between RFP and ErbB2 expression.
    Tezel GG; Uner A; Yildiz I; Guler G; Takahashi M
    Pathol Res Pract; 2009; 205(6):403-8. PubMed ID: 19232840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth factor receptor expression in anal squamous lesions: modifications associated with oncogenic human papillomavirus and human immunodeficiency virus.
    Walker F; Abramowitz L; Benabderrahmane D; Duval X; Descatoire V; Hénin D; Lehy T; Aparicio T
    Hum Pathol; 2009 Nov; 40(11):1517-27. PubMed ID: 19716155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD109 expression in basal-like breast carcinoma.
    Hasegawa M; Moritani S; Murakumo Y; Sato T; Hagiwara S; Suzuki C; Mii S; Jijiwa M; Enomoto A; Asai N; Ichihara S; Takahashi M
    Pathol Int; 2008 May; 58(5):288-94. PubMed ID: 18429827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metaplastic breast carcinoma: pathology and clinical outcome.
    Bellino R; Arisio R; D'Addato F; Attini R; Durando A; Danese S; Bertone E; Grio R; Massobrio M
    Anticancer Res; 2003; 23(1B):669-73. PubMed ID: 12680165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sporadic invasive breast carcinomas with medullary features display a basal-like phenotype: an immunohistochemical and gene amplification study.
    Rodríguez-Pinilla SM; Rodríguez-Gil Y; Moreno-Bueno G; Sarrió D; Martín-Guijarro Mdel C; Hernandez L; Palacios J
    Am J Surg Pathol; 2007 Apr; 31(4):501-8. PubMed ID: 17414096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6.
    Mukhopadhyay S; Katzenstein AL
    Am J Surg Pathol; 2011 Jan; 35(1):15-25. PubMed ID: 21164283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coordinated expression of oestrogen and androgen receptors in HER2-positive breast carcinomas: impact on proliferative activity.
    Lin Fde M; Pincerato KM; Bacchi CE; Baracat EC; Carvalho FM
    J Clin Pathol; 2012 Jan; 65(1):64-8. PubMed ID: 22039288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features.
    Perrone G; Santini D; Vincenzi B; Zagami M; La Cesa A; Bianchi A; Altomare V; Primavera A; Battista C; Vetrani A; Tonini G; Rabitti C
    Histopathology; 2005 May; 46(5):561-8. PubMed ID: 15842638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of CD24 and claudin-7 immunoexpression in ductal invasive breast cancer.
    Bernardi MA; Logullo AF; Pasini FS; Nonogaki S; Blumke C; Soares FA; Brentani MM
    Oncol Rep; 2012 Jan; 27(1):28-38. PubMed ID: 21956537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequent overexpression of epidermal growth factor receptor (EGFR) in mammary high grade ductal carcinomas with myoepithelial differentiation.
    Shien T; Tashiro T; Omatsu M; Masuda T; Furuta K; Sato N; Akashi-Tanaka S; Uehara M; Iwamoto E; Kinoshita T; Fukutomi T; Tsuda H; Hasegawa T
    J Clin Pathol; 2005 Dec; 58(12):1299-304. PubMed ID: 16311351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of expression of androgen receptor may play a critical role in transformation from in situ to invasive basal subtype of high-grade ductal carcinoma of the breast.
    Hanley K; Wang J; Bourne P; Yang Q; Gao AC; Lyman G; Tang P
    Hum Pathol; 2008 Mar; 39(3):386-92. PubMed ID: 18187183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical detection of epidermal growth factor receptor lacks prognostic significance for breast carcinoma.
    Göhring UJ; Ahr A; Scharl A; Weisner V; Neuhaus W; Crombach G; Holt JA
    J Soc Gynecol Investig; 1995; 2(4):653-9. PubMed ID: 9420872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of vascular endothelial growth factor in squamous cell carcinomas of the tonsil in relation to human papillomavirus status and epidermal growth factor receptor.
    Fei J; Hong A; Dobbins TA; Jones D; Lee CS; Loo C; Al-Ghamdi M; Harnett GB; Clark J; O'Brien CJ; Rose B
    Ann Surg Oncol; 2009 Oct; 16(10):2908-17. PubMed ID: 19603236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Basal cytokeratin expression in relation to biological factors in breast cancer.
    Kuroda H; Ishida F; Nakai M; Ohnisi K; Itoyama S
    Hum Pathol; 2008 Dec; 39(12):1744-50. PubMed ID: 18755493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast infiltrating ductal carcinoma: analysis of hormone, HER-2 receptors and Ki-67 proliferation marker.
    Mustać E; Zamolo G; Petković M; Dordević G; Radić J; Grgurević E; Batinac T
    Coll Antropol; 2008 Sep; 32(3):741-6. PubMed ID: 18982746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.